Effect of addition of L –Carnitine in Polycystic Ovary Syndrome (PCOS) Patients With Resistant Clomiphene Citrate and Gonodotropin Treatment

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2014030213566N2

Enrollment

Registered

2014-04-23

Start date

2014-04-05

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female infertility associated with anovulation

Interventions

L - carnitine from day 3 starting clomiphene citrate every 12 hours 2 vials (each vial, 1 g).

Treatment - Drugs

L - carnitine from day 3 starting clomiphene citrate every 12 hours 2 vials (each vial, 1 g)

Eligibility

Sex/Gender

Female

Age

20 Years to 35 Years

Inclusion criteria

Inclusion criteria: Encloses Criteria: Patients with infertility resistant to clomiphene citrate and gonadotropin regimens in age from 20-35 years with normal FSH and LH and AMH and estradiol Exclusion criteria:patient is allergic to L-Carnitine, not wanting , family history of infertility, If have heart disease and lung

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Growth of the dominant follicle. Timepoint: The first 15 day menstrual cycle. Method of measurement: Ultrasound.	—

Secondary

Measure	Time frame
Achieving pregnancy. Timepoint: 16 days after injection of Hcg. Method of measurement: Blood tests.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Kobra Hamdi

Tabriz University of Medical Sciences

hamdi_kobra@yahoo.com; wrhrcenter@gmail.com; lahrodi59@yahoo.com+98 41 1554 1221

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026